KLP Kapitalforvaltning’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$165M Buy
1,277,070
+80,200
+7% +$9.39M 0.53% 30
2026
Q1
$145M Sell
1,196,870
-78,400
-6% -$9.05M 0.57% 24
2025
Q4
$135M Sell
1,275,270
-48,900
-4% -$4.59M 0.52% 25
2025
Q3
$112M Buy
1,324,170
+44,100
+3% +$3.63M 0.44% 31
2025
Q2
$102M Buy
1,280,070
+52,000
+4% +$4.13M 0.44% 32
2025
Q1
$111M Buy
1,228,070
+80,900
+7% +$7.55M 0.54% 25
2024
Q4
$115M Buy
+1,147,170
New +$118M 0.54% 26

Other funds holding MRK

KLP Kapitalforvaltning's MRK Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Merck (MRK) stake by 6.7% in Q2 2026, buying an estimated $9.39M and bringing the position to 1,277,070 shares worth $165M. The position accounts for 0.53% of the portfolio, ranked #30.

KLP Kapitalforvaltning first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • KLP Kapitalforvaltning held 1,277,070 shares of Merck worth $165M as of Q2 2026.
  • KLP Kapitalforvaltning bought 80,200 Merck shares in Q2 2026, an estimated $9.39M.
  • Merck made up 0.53% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #30 holding.
  • KLP Kapitalforvaltning first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.